September 19, 2007 NASD OTC-BB: MRDAF

Meridian's DPA Receives "Korean World-Class Product Award"

As further evidence that the wellness industry owns one of the most innovative product segments within the global economy, Meridian Co., Ltd. (OTC BB:MRDAF.OB - News) ("Meridian" or the "Company") has been awarded a "Korean World-Class Product Award" for its Digital Pulse Analyzer (DPA) which measures the elasticity and estimated real age of human arteries with just a touch of a finger.

The award was recently presented to Meridian's founder, Hyeon Seong Myeong, by Korea's Minister of Commerce, Industry and Energy on behalf of the award sponsor, the Korea Industrial Technology Foundation (KOTEF).

"On behalf of everyone at Meridian, we are so pleased that the KOTEF has recognized the DPA as a World-Class product," said Myeong. "With products that focus on prevention of disease like the DPA and its component Heart Rate Variability software, medical professionals and wellness practitioners around the world now have a painless, simple and easily portable means to accurately measure their clients' risk for cardiovascular disease."

Two hundred products were initially selected from various industrial sectors based on recommendations by several Korean business associations. After an initial review, 75 products were selected for a third screen which yielded 27 products worthy of the World Class Award. Products from the major Korean manufacturers were also included. LG Electronics' high-definition disk player and SK's Lithium Ion Battery Separator (LIBS) were also selected.

As a KOTEF's awarded company, Meridian is qualified to participate in the World-Class Product Tradeshow and receive other forms of marketing support from the KOTEF. KOTEF sponsors the Korean World-Class Product Award competition every year to advocate innovative practices among industry technology innovators.

More About: KOTEF

KOTEF is an organization established to develop and promote industrial technology by establishing the industry, academy, institution cooperative system and expanding the industrial technology base. For more information about KOTEF please visit http://english.kotef.or.kr/.

More About: Digital Pulse Analyzer ("DPA")

The DPA accurately measures the elasticity of small and large arteries and provides health care practitioners with critical information regarding arterial aging. This FDA-cleared and Health Canada approved device is inexpensive, non-invasive, and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions.

Cardiovascular disease is the number one killer of both men and women in the United States with an estimated economic cost of approximately $298 billion. The Company feels that use of the DPA can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention, and ultimately assist to decrease the associated financial costs placed on the health care industry.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 1500 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

By continuing its commitment for the globalization and advancement of integrative medical products, Meridian seeks to transform health care from a focus on disease to a focus on wellness and prevention. By working towards this vision, Meridian can ensure it becomes a world-class company for its customers and could ultimately decrease the financial burden placed on the existing, expensive, allopathic health care industry.

On Behalf of the Board of Directors, Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contacts:
Meridian Co., Ltd.
Peter Holeczek
Corporate Communications
1-866-736-3306
Website: https://MeridianMedical.ca